Radiopharm RAD 101 meets Phase 2b endpoint in brain metastases
Go back to Radiopharm RAD 101 meets Phase 2b endpoint in brain metastases| (NASDAQ: RADX) | Delayed: 0.95 -0.03 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.98 | 52 Week High | $ | |||
| Open | $0.95 | 52 Week Low | $ | |||
| Day High | $0.99 | P/E | N/A | |||
| Day Low | $0.95 | EPS | $ | |||
| Volume | 5,301 | |||||



